Advertisement

Psychopharmacology

, Volume 83, Issue 1, pp 1–16 | Cite as

The validity of animal models of depression

  • Paul Willner
Review

Abstract

Eighteen animal, models of depression are reviewed in relation to three sets of validating criteria. Of the 18 models, five could only be assessed for predictive, validity, seven could be assessed for predictive and face validity, and six could potentially have predictive, face and construct validity. Some traditional models (reserpine reversal, amphetamine potentiation) are rejected as invalid; the models with the highest overall validity are the intracranial self-stimulation, chronic stress and learned helplessness models in rats, and the primate separation model.

Key words

Animal models Depression Validity 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ainsworth MDS (1976) Discussion of papers by Suomi and Bowlby. In: Serban G, Kling A (eds) Animal models in human psychobiology. Plenum Press, New York, pp 37–47Google Scholar
  2. Akiskal HS (1979) A biobehavioural approach to depression. In: Depue RA (ed) The psychobiology of the depressive disorders: Implications for the effects of stress. Academic Press, New York, pp 409–437Google Scholar
  3. Akiskal HS (1980) External validating criteria for psychiatric diagnosis: Their application in affective disorders. J. Clin Psychiatry 41:12. Sec.2:6–15Google Scholar
  4. Akiskal HS, McKinney WT (1973) Depressive disorders: Toward a unified hypothesis. Science 182:20–29Google Scholar
  5. Altenor A, Kay E, Richter M (1977) The generality of learned helplessness in the rat. Learning and Motivation 8:54–61Google Scholar
  6. American Psychiatric Association (1980) DSM III — Diagnostic and statistical manual of psychiatric disorders. A.P.A., WashingtonGoogle Scholar
  7. Anderson DC, Cole J, McVaugh W (1968) Variations in unsignalled inescapable preshock as determinants of responses to punishment. J Comp Physiol Psychol 65 [Suppl]: 1–17Google Scholar
  8. Anisman H, Remington G, Sklar LS (1979) Effects of inescapable shock on subsequent escape performance: catecholaminergic and cholinergic mediation of response initiation and maintenance. Psychopharmacology 61:107–124Google Scholar
  9. Anisman HA, Zacharko RM (1982) Depression: The predisposing influence of stress. Behav Brain Sci 5:89–137Google Scholar
  10. Aprison MH, Hintgen JN, Nagayama H (1982) Testing a new theory of depression with an animal model: Neurochemical-behavioural evidence for postsynaptic serotonergic receptor involvement. In: Langer SZ, Takahashi R, Segawa T, Briley M (eds) New vistas in depression. Pergamon Press, New York, pp 171–178Google Scholar
  11. Askew BM (1963) A simple screening procedure for imipramine-like anti-depressant drugs. Life Sci 2:725–730Google Scholar
  12. Babington RG (1975) Antidepressives and the kindling effect. In: Fielding S, Lal H (eds) Antidepressants. Futura, Mount Kisco, New York, pp 113–124Google Scholar
  13. Babington RG (1981) Neurophysiologic techniques and antidepressive activity. In: Enna SJ, Malick JB, Richelson E (eds) Antidepressants: Neurochemical, behavioural and clinical perspectives, Raven Press, New York, pp 157–173Google Scholar
  14. Babington RG, Wedeking, PW (1973) The pharmacology of seizures induced by sensitization with low intensity brain stimulation. Pharmacol Biochem Behav 1:461–467Google Scholar
  15. Baltzer V, Weiskrantz L (1973) Antidepressant agents and reversal of diurnal activity cycles in the rat. Biol Psychiatry 10:199–209Google Scholar
  16. Barnett A, Taber RI (1971) Antidepressant agents. In: Turner RA, Hebborn P (eds) Screening methods in pharmacology. Academic Press, New York, pp 209–226Google Scholar
  17. Barnett A, Taber RI, Roth RE (1969) Activity of antihistamines in laboratory antidepressant tests. Int J Pharmacol 8:73–79Google Scholar
  18. Barrett RJ, White DK (1980) Reward system depression following chronic amphetamine: antagonism by haloperidol. Pharmacol Biochem Behav 13:555–559Google Scholar
  19. Beck AT, Harrison RP (1982) Stress, neurochemical substrates and depression: Concommitants are not necessarily causes. Behav Brain Sci 5:101–102Google Scholar
  20. Belmaker RH, Lerer B, Zohar J (1982) Salbutamol treatment of depression. In: Costa E, Racagni G (eds) Typical and atypical antidepressants: Clinical practice. Raven Press, New York, pp 181–193Google Scholar
  21. Betin C, DeFeudis FV, Blavet N, Clostre F (1982) Further characterization of the behavioural despair test in mice: Positive effects of convulsants. Physiol Behav 28:307–311Google Scholar
  22. Binks SM (1979) A reward reduction model of depression using self-stimulating rats: an appraisal. Pharmacol Biochem Behav 10:441–443Google Scholar
  23. Blaney PH (1977) Contemporary theories of depression: critique and comparison. J Abnorm Psychol 86:203–223Google Scholar
  24. Bowden DM, McKinney WT (1972) Behavioural effects of peer separation, isolation and reunion on adolescent male rhesus monkeys. Dev Psychobiol 5:353–362Google Scholar
  25. Bowlby J (1976) Human personality development in an ethological light. In: Serban G, Kling A (eds) Animal models in human psychobiology. Plenum Press, New York, pp 27–36Google Scholar
  26. Briscoe CW, Smith JB (1975) Depression in bereavement and divorce. Arch Gen Psychiatry 32:439–443Google Scholar
  27. Brodie BB, Bickel MH, Sulser F (1961) Desmethylimipramine, a new type of antidepressant drug. Med Exp 5:454–458Google Scholar
  28. Broekkamp CL, Garrigou D, Lloyd KG (1980) Serotonin-mimetic and antidepressant drugs on passive avoidance learning by olfactory bulbectomized rats. Pharmacol Biochem Behav 13:643–646Google Scholar
  29. Brown GW, Harris T (1978) Social origins of depression. Tavistock Publications, LondonGoogle Scholar
  30. Browne RG (1979) Effects of antidepressants and anticholinergics in a mouse “behavioural despair” test. Eur J Pharmacol 58:331–334Google Scholar
  31. Burchfield SR (1979) The stress response: A new perspective. Psychosom Med 41:661–672Google Scholar
  32. Cairncross KD, Wren AF, Cox B, Schnieden H (1977) Effects of olfactory bulbectomy and domicile on stress induced corticosterone release in the rat. Physiol Behav 19:485–487Google Scholar
  33. Cairncross KD, Cox B, Forster C, Wren AF (1978) A new model for the detection of antidepressant drugs: Olfactory bulbectomy in the rat compared with existing models. J Pharmacol Methods 1:131–143Google Scholar
  34. Cairncross KD, Cox B, Forster C, Wren, AF (1979) Olfactory projection systems, drugs and behaviour: A review. Psychoneuroendocrinology 4:253–272Google Scholar
  35. Carlsson A, Lindqist M, Magnusson T (1957) 3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists. Nature 180:1200Google Scholar
  36. Carlton PL (1961) Potentiation of the behavioural effects of amphetamine. Psychopharmacology 2:364–376Google Scholar
  37. Carroll BK (1978) Neuroendocrine function in psychiatric disorders. In: Lipton MA, DiMaschio A, Killam KF (eds) Psychopharmacology: A generation of progress, Raven Press, New York, pp 487–497Google Scholar
  38. Carroll BJ, Curtis GC, Mendels J (1976) Cerebrospinal fluid and plasma free cortisol levels in depression. Psychol Med 6:235–244Google Scholar
  39. Claasen V, Davies JE (1969) Potentiation by tricyclic antidepressants of weight loss caused by amphetamine in rats. Acta Physiol Pharmacol Nederl 15:37–40Google Scholar
  40. Colpaert FC, Lenaerts FM Niemegeers CJE, Janssen PAJ (1975) A critical study on RO-4-1284 antagonism in mice. Arch Int Pharmacodyn Ther 215:40–90Google Scholar
  41. Cornfeldt M, Fisher B, Fielding S (1982) Rat internal capsule lesion: a new test for detecting antidepressants. Fed Proc 41:1066Google Scholar
  42. Costa E, Racagni G (1982) Typical and atypical antidepressants: Clinical practice. Raven Press, New YorkGoogle Scholar
  43. Costa E, Garattini S Valzelli L (1960) Interactions between reserpine, chlorpromazine and imipramine. Experientia 16:461–463Google Scholar
  44. Costello CG (1972) Depression: Loss of reinforcers or loss of reinforcer effectiveness? Behav Ther 3:240–247Google Scholar
  45. Cresse I, Snyder SH (1978) Behavioural and biochemical properties of the dopamine receptor. In: Lipton MA, DiMaschio A, Killam KF (eds) Psychopharmacology: A generation of progress. Raven Press, New York, pp 377–388Google Scholar
  46. Day MD, Rand MJ (1963) Awakening from reserpine sedation by alpha-methyl dopa. J Pharm Pharmacol 15:631–632Google Scholar
  47. Delina-Stula A, Vassout A (1979) Differential effects of psychoactive drugs on aggressive responses in rats and mice. In: Sandler M (ed) Psychopharmacology of aggression. Raven Press, New York, pp 41–60Google Scholar
  48. Depue, RA, Monroe SM (1978) Learned helplessness in the perspective of the depressive disorders: Conceptual and definitional issues. J Abnorm Psychol 87:3–20Google Scholar
  49. Depue RA, Monroe SM (1979) The unipolar-bipolar distinction in the depressive disorders: implications for stress-onset interactions. In: Depue RA (ed) The psychobiology of the depressive disorders: Implications for the effects of stress. Academic Press, New York, pp 23–53Google Scholar
  50. Donnelly EF, Murphy DL (1973) Primary affective disorder —MMPI differences between unipolar and bipolar depressed subjects. J Clin Psychol 29:303–306Google Scholar
  51. Dorworthy TR, Overmeier JB (1977) On “learned helplessness”: The therapeutic effects of electroconvulsive shock. Physiol Behav 4:355–358Google Scholar
  52. Dubinsky B, Goldberg ME (1971) The effect, of imipramine and selected drugs on attack elicited by hypothalamic stimulation in the cat. Neuropharmacology 10:537–545Google Scholar
  53. Dubinsky B, Karpowicz K, Goldberg M (1973) Effects of tricyclic antidepressants on attack elicited by hypothalamic stimulation: Relation to brain biogenic amines. J Pharmacol Exp Ther 18:550–552Google Scholar
  54. Duvoisin RC, Marsden CD (1974) Reversal of reserpine-induced bradykinesia by alpha-methyldopa: New light on its modus operandi. Brain Res 71:178–182Google Scholar
  55. Einon DF, Morgan MJ, Sahakian BJ (1975) The development of intersession habituation and emergence in socially reared and isolated rats. Dev Psychobiol 8:553–559Google Scholar
  56. Emrich HM (1982) A possible role of opioid actions in endogenous depression. In: Langer SZ, Takahashi R, Segawa, T, Briley M (eds) New vistas in depression. Pergamon Press, New York, pp 233–237Google Scholar
  57. Engel GL (1962) Anxiety and depression withdrawal: The primary effects of unpleasure. Int J Psychoanal 43:89–97Google Scholar
  58. Everett GM (1967) The DOPA response potentiation test and its use in screening for antidepressant drugs. In: Garattini S, Dukes, MNG (eds) Antidepressant drug. Excerpta Medica, Amsterdam, pp 164–167Google Scholar
  59. Everitt BJ, Keverne EB (1979) Models of depression based on behavioural observations of experimental animals In: Paykel ES, Copen, A (eds) Psychopharmacology of affective disorders. Oxford University Press, Oxford, pp 41–59Google Scholar
  60. Ferris RM, Maxwell RA, Cooper BR, Soroko FE (1982) Neurochemical and neuropharmacological investigations into the mechanisms of action of bupropion-HCl — a new atypical antidepressant agent. In: Costa E, Racagni G (eds) Typical and atypical antidepressants: Molecular mechanisms. Raven Press, New York, pp 277–286Google Scholar
  61. Ferster CB (1973) A functional analysis of depression. Am Psychol 28:857–870Google Scholar
  62. Fibiger HC, Phillips AG (1981) Increased intracranial self-stimulation in rats after long-term administration of desipramine. Science 214:683–685Google Scholar
  63. Gallistel CR, Beagley G (1971) Specificity of brain stimulation reward in the rat. J Comp Physiol Psychol 76:199–205Google Scholar
  64. Garber J, Miller WR, Seaman SF (1979) Learned helplessness, stress and the depressive disorders. In: Depue RA (ed) The psychobiology of the depressive disorders: Implications for the effects of stress. Academic Press, New York, pp 335–363Google Scholar
  65. Garzon J, Del Rio J (1981) Hyperactivity induced in rats by longterm isolation: further studies on a new animal model for the detection of antidepressants. Eur J Pharmacol 74:287–294Google Scholar
  66. Garzon J, Fuentes JA, Del Rio J (1979) Antidepressants selectively antagonize the hyperactivity induced in rats by long-term isolation. Eur J Pharmacol 59:293–296Google Scholar
  67. Gersh FS, Fowles DC (1979) Neurotic depression: The concept of anxious depression. In: Depue RA (ed) The psychobiology of the depressive disorders: Implications for the effect of stress. Academic Press, New York, pp 81–104Google Scholar
  68. Gillin JC (1983) The sleep therapies of depression. Prog Neuropsychopharmacol 7:351–364Google Scholar
  69. Goddard GV, McIntyre DC, Leech CK (1969) A permanent change in brain function resulting from daily electrical stimulation. Exp Neurol 25:295–330Google Scholar
  70. Goodwin FK, Ebert MH, Bunney WE (1972) Mental effects of reserpine in man: A review. In: Shader RI (ed), Psychiatric complications of medical drugs. Raven Press, New York, pp 73–101Google Scholar
  71. Goodwin FK, Wirz-Justice A, Wehr TA (1982) Evidence, that pathophysiology of depression and the mechanism of action of antidepressant drugs both involve alterations in circadian rhythms. In: Costa E, Racagni G (eds) Typical and atypical antidepressants: Clinical practice. Raven Press, New York, pp 1–11Google Scholar
  72. Gorka Z, Wojtasik E (1980) The effect of antidepressants on behavioural despair in rats. Pol J Pharmacol Pharm 32:463–468Google Scholar
  73. Gorka Z, Wojtasik, E, Kwiatek H, Maj J (1979) Action of serotoninmimetics in the behavioural despair test in rats. Commun Psychopharmacol 3:133–136Google Scholar
  74. Grabowska M, Antkiewicz L, Mechaluk J (1974) The influence of LSD on locomotor activity in reserpinized mice. Pol J Pharmacol Pharm 26:499–504Google Scholar
  75. Halliwell G, Quinton RM, Williams DE (1964) A comparison of imipramine, chlopromazine and related drugs in various tests involving autonomic functions and antagonism, of reserpine. Br J Pharmacol 23:330–350Google Scholar
  76. Hatotani N, Nomura J, Kitayama I (1982) Changes of brain monoamines in the animal model for depression. In: Langer SZ, Takahashi R, Segawa T, Briley M (eds) New vistas in depression. Pergamon Press, New York, pp 65–72Google Scholar
  77. Heath RG (1963) Electrical self-stimulation of the brain in man. Am J Psychiatry 120:571–577Google Scholar
  78. Heath, RG, John SB, Fontana CJ (1968) The pleasure response: Studies by stereotaxic techniques in patients. In: Kline NS, Laska E (eds) Computer and electronic devices in psychiatry. Grune and Stratton, New York, pp 178–189Google Scholar
  79. Higley JD, Suomi SJ, Scanlon JM, McKinney WT (1982) Plasma cortisol as a predictor of individual depressive behaviour in rhesus monkeys (Macaca mulatta) Soc Neurosci Abstr 8:461Google Scholar
  80. Hill RT, Tedeschi DH (1971) Animal testing and screening procedures in evaluating psychotropic drugs. In: Rech RH, Moore KE (eds) An introduction to psychopharmacology. Raven Press, New York, pp 237–288Google Scholar
  81. Hinde RA, McGinnis L (1977) Some factors influencing the effects of temporary mother-infant, separation. Some experiments with rhesus monkeys. Psychol Med 7:197–212Google Scholar
  82. Hinde RA, Leighton-Shapiro ME, McGinnis L (1978) Effects of various types of separation experience on rhesus monkeys 5 months later. J Child Psychol Psychiatr 19:199–211Google Scholar
  83. Hoebel BG (1976) Brain-stimulation reward and aversion in relation to behaviour. In: Wauquier A, Rolls E (eds) Brain-stimulation reward. North Holland/American Elsevier. New York, pp 331–372Google Scholar
  84. Hoebel BG Teitelbaum P (1962) Hypothalamic control of feeding and self-stimulation. Science 135:375–377Google Scholar
  85. Horowitz ZP (1965) Selective block or rat mouse killing by antidepressants. Life Sci 4:1909–1912Google Scholar
  86. Horovitz ZP (1967) The amygdala and depression. In: Garattini S, Dukes MNG (eds) Antidepressant drugs. Excerpta Medica, Amsterdam, pp 121–129Google Scholar
  87. Horowitz ZP, Piala JJ, High JP, Burke JC, Leaf RC (1966) Effects of drugs on the mouse killing (muricide) test and its relationship to amygdaloid function. Int J Neuropharmacol 5:405–411Google Scholar
  88. Howard JL, Soroko FE, Cooper BR (1981) Empirical behavioural models of depression, with emphasis on tetrabenazine antagonism. In: Enna SJ, Malick JB, Richelson E (eds) Antidepressants: Neurochemical, behavioural and clinical perspectives. Raven Press, New York, pp 107–120Google Scholar
  89. Hrdina PD, Von Kulmiz P, Stretch R (1979) Pharmacological modification of experimental depression in infant macaques. Psychopharmacology 64:89–93Google Scholar
  90. Hudgens H, Morrison J, Barcha R (1967) Life events and onset of primary affective disorders. Arch Gen Psychiatry 16:134–145Google Scholar
  91. Johnson DN, Funderburk WH, Ward JW (1970) Preclinical evaluation of AHR-118: A potential antidepressant drug. Curr Ther Res 12:402–413Google Scholar
  92. Kashani JH, Husain A, Shekim WO, Hodges KK, Cytryn L, McKnew DH (1981) Current perspectives on childhood depression: An overview. Am J Psychiatry 138:143–153Google Scholar
  93. Kastin AJ, Scollan EL, Ehrensing RH, Schally AV, Coy DH (1978) Enkephalin and other peptides reduce passiveness Pharmacol Biochem Behav 9:515–519Google Scholar
  94. Katz RJ (1981a) Animal models and human depressive disorders. Neurosci Biobehav Rev 5:231–246Google Scholar
  95. Katz RJ (1981b) Animal model of depression: Effects of electroconvulsive shock therapy. Neurosci Biobehav Rev 5:273–277Google Scholar
  96. Katz RJ (1982) Animal model of depression: Pharmacological sensitivity of a hedonic deficit. Pharmacol Biochem. Behav 16:965–968Google Scholar
  97. Katz RJ, Baldrighi G (1982) A further parametric study of imipramine in an animal model of depression. Pharmacol Biochem Behav 16:969–972Google Scholar
  98. Katz RJ, Hersh S (1981) Amitriptyline and scopolamine in an animal model of depression. Neurosci Biobehav Rev 5:265–271Google Scholar
  99. Katz RJ, Sibel M (1982a) Animal model of depression: tests of three structurally and pharmacologically novel antidepressant compounds. Pharmacol Biochem Behav 16:973–977Google Scholar
  100. Katz RJ, Sibel M (1982b) Further analysis of the specificity of a novel animal model of depression: Effects of an antihistaminic, antipsychotic and anxiolytic compound. Pharmacol Biochem Behav 16:979–982Google Scholar
  101. Katz RJ, Roth KA, Carroll BJ (1981a) Acute and chronic stress effects on open field activity in the rat: implications for a model of depression. Neurosci Biobehav Rev 5:247–251Google Scholar
  102. Katz RJ, Roth KA, Schmaltz K (1981b) Amphetamine and tranylcypromine in an animal model of depression: pharmacological specificity of the reversal effect. Neurosci Biobehav Rev 5:259–264Google Scholar
  103. Kaufman IC, Rosenblum LA (1967) the reaction to separation in infant monkeys: Anaclitic, depression and conservation-withdrawal. Psychosom. Med 29:648–675Google Scholar
  104. Kaufman IC, Stynes AJ (1978) Depression, can be induced in a bonnet macaque infant. Psychosom Med 40: 71–75Google Scholar
  105. Kitada Y, Miyauchi T, Satoh A, Satoh S (1981) Effects of antidepressants in the rat forced swimming test. Eur J Pharmacol 72:145–152Google Scholar
  106. Klein DF (1974) Endogenomorphic depression: A conceptual and terminological revison. Arch Gen Psychiatry 31:447–454Google Scholar
  107. Klinger E (1975) Consequences of commitment to and disengagement from incentives. Psychol Rev 82:1–24Google Scholar
  108. Klinger E, Barta SG, Kemble ED (1974) Cyclic activity changes during extinction in rats: A potential model of depression. Anim Learn Behav 2:313–316Google Scholar
  109. Knobloch LC, Goldstein JR, Malick JB (1982) Effects of acute and subacute antidepressant treatment on kindled seizures in rats. Pharmacol Biochem Behav 17:461–465Google Scholar
  110. Kokkindis L, Zacharko RM (1980) Response sensitization and depression following long-term amphetamine treatment in a self-stimulation paradigm. Psychopharmacology 68:73–76Google Scholar
  111. Kokkinidis L, Zacharko RM, Predy PA (1980) Post-amphetamine depression of self-stimulation responding from, the substantia nigra: reversal by tricyclic antidepressants. Pharmacol Biochem Behav 13:379–383Google Scholar
  112. Kraemer GW, McKinney WT (1979) Interactions of pharmacological agents which alter biogenic amine metabolism, and depression. J Affect Dis 1:33–54Google Scholar
  113. Kupfer DJ (1976) REM latency: A psychobiological marker for primary depressive disease. Biol Psychiatry 11:159–174Google Scholar
  114. Kupfer DJ, Detre TP (1978) Tricyclic and monoamine-oxidase inhibitor antidepressants: Clinical use. In: Iversen LL, Iversen SD, Snyder SH (eds) Handbook of psychopharmacology Vol 14. Plenum Press, New York, pp 199–232Google Scholar
  115. Lang W, Gershon S (1962) Effect, of psychoactive drugs on yohimbine-induced responses in conscious dogs. A study of antidepressant drugs. Med Exp (Basel) 7:125–134Google Scholar
  116. Lang W, Gershon S (1963) Effects of psychoactive drugs on yohimbine-induced responses in conscious dogs. A proposed screening procedure for anti-anxiety agents. Arch. Int Pharmacodyn 142:457–472Google Scholar
  117. Lapin IP (1980), Adrenergic nonspecific potentiation of yohimbine toxicity in mice by antidepressants and related drugs and antiyohimbine action of antiadrenergic and serotonergic drugs. Psychopharmacology 70:179–185Google Scholar
  118. Leith NJ, Barrett RJ (1976) Amphetamine and the reward system: evidence for tolerance and post-drug depression. Psychopharmacology 46:19–25Google Scholar
  119. Leith NJ, Barrett RJ (1980) Effects of chronic amphetamine or reserpine on self-stimulation: animal model of depression? Psychopharmacology 72:9–15Google Scholar
  120. Leonard BE (1982) On the mode of action of mianserin. In: Costa E, Racagni G (eds) Typical and atypical antidepressants: Molecular mechanisms. Raven Press, New York, pp 301–319Google Scholar
  121. Leshner AI, Remler H, Biegon A, Samuel D (1979) Effects of desmethylimipramine, (DMI) on learned helplessness. Psychopharmacology 66:207–213Google Scholar
  122. Lewander T (1968) Effects of amphetamine on urinary and tissue catecholamines in rats after inhibition of its metabolism with desmethylimiparamine. Eur J Pharmacol 5:1–9Google Scholar
  123. Lewinsohn PM (1974) A behavioural approach to depression. In: Friedman RJ, Katz MM (eds) The psychology of depression: Contemporary theory and research. Winston/Wiley, New York, pp 157–185Google Scholar
  124. Lewinsohn PM, Zeiss AM, Zeiss RA, Haller R (1977) Endogenicity and reactivity as orthogonal dimensions in depression. J Nerv Ment Dis 164:327–332Google Scholar
  125. Lewinsohn PM, Yougren, MA, Grosscup SJ (1979) Reinforcement and depression. In: Depue RA (ed) The psychobiology of the depressive desorders: Implications for the effects of stress. Academic Press, New York, pp 291–316Google Scholar
  126. Lewis JK, McKinney WT (1976) Effects of electroconvulsive shock on the behaviour of normal and abnormal rhesus monkeys. Behav Psychiatr 37:687–693Google Scholar
  127. Lewis JK, McKinney WT, Young LD, Kraemer GW (1976) Motherinfant separation in rhesus monkeys as a model of human depression: A reconsideration. Arch Gen Psychiatry 33:699–705Google Scholar
  128. Liebman J (1983) Discriminating between reward and performance: A critical review of intracranial self-stimulation methodology. Neurosci Biobehav Rev 7:45–72Google Scholar
  129. Lishman WA (1972) Selective factors, in memory. Psychol Med 2:248–253Google Scholar
  130. Lloyd C (1980a) Life events and depressive disorder reviewed. I. Events as predisposing factors. Arch Gen Psychiatry 37:529–535Google Scholar
  131. Lloyd C (1980b) Life events and depressive disorders reviewed. II. Events as precipitating factors. Arch Gen Psychiatry 37:541–548Google Scholar
  132. Lloyd KG, Garrigou D, Broekkamp CLE (1982) The action of monoaminergic, cholinergic and gabaergic compounds in the olfactory bulbectomized rat model of depression. In: Langer SZ, Takahashi R, Segawa T, Briley M (eds) New vistas in depression. Pergamon Press, New York, pp 179–186Google Scholar
  133. Maier SF, Seligman MEP (1976) Learned helplessness: Theory and evidence. J Exp Psychol (Gen) 1:3–46Google Scholar
  134. Maier SF, Anderson C, Lieberman DA (1972) Influence of control of shock on subsequent shock-elicited aggression. J Comp Physiol Psychol 81:94–100Google Scholar
  135. Malick JB (1981) Yohimbine potentiation as a predictor of antidepressant action. In: Enna SJ, Malick JB, Richelson E (eds) Antidepressants: Neurochemical, behavioural and clinical perspectives. Raven Press, New York, pp 141–155Google Scholar
  136. Martorana PA, Nitz RE (1979) The new antidepressant pirlindone: A comparison with imipramine and tranylcypromine. Arzneim Forsch 29:946–949Google Scholar
  137. Maxwell DR, Palmer HT (1961) Demonstration of anti-depressant or stimulant properties of imipramine in experimental animals. Nature 191:84–85Google Scholar
  138. McKinney WT, Bunney WE (1969) Animal model of depression: Review of evidence and implications for research. Arch Gen Psychiatry 21:240–248Google Scholar
  139. McKinney WT, Young LD, Suomi SJ (1973) Chlorpromazine treatment of disturbed monkeys. Arch Gen Psychiatry 29:490–494Google Scholar
  140. McKnew DH, Cytryn L (1973) Historical background in children with affective disorders. Am J Psychiatry 130:1278–1280Google Scholar
  141. Menzel EW Dvenport RK, rogers CM (1963) Effects of environmental restriction upon the chimpanzee's responsiveness to objects. J Comp Physiol Psychol 56:78–85Google Scholar
  142. Miller W, Rosellini RA, Seligman MEP (1977) Learned helplessness and depression. In: Maser JD, Seligman MEP (eds) Psychopathology: Experimental models. Freeman, San Francisco, pp 104–130Google Scholar
  143. Morgan MJ, Einon DF, Nicholas D (1975) The effects of isolation rearing on behavioural inhibition in the rat. Q J Exp Psychol 27:615–634Google Scholar
  144. Morpurgo C, Theobald W (1965) Effect of imipramine-like compounds and chlorpromazine on reserpine-hypothermia in mice and amphetamine-hyperthermia in rats. Med Pharmacol Exp 2:226–232Google Scholar
  145. Nagayama H, Hintgen, JN, Aprison MH (1980) Pre- and postsynaptic serotonergic manipulations in an animal of depression. Pharmacol Biochem Behav 13:575–579Google Scholar
  146. Nagayama H, Hintgen JN, Aprison MH (1981) Postsynpatic action by four antidepressive drugs in an animal model of depression. Pharmacol Biochem Behav 15:125–130Google Scholar
  147. Nagy A (1977) Blood and brain concentrations of imipramine, clomipramine and their monomethylated metabolites, after oral and intramuscular administration in rats. J Pharm Pharmacol 29:104–107Google Scholar
  148. Nelson JC, Charney DS (1981) The symptoms of major depression. Am J Psychiatry 138:1–13Google Scholar
  149. Nomura A, Shimizu J, Kamateni H, Kinjo M, Watanabe M, Nakazawa T (1982) Swimming mice: In search, of an animal model for human depression. In: Langer SZ, Takahashi R, Segawa T, Briley M (eds) New vistas in depression. Pergamon Press, New York, pp 203–210Google Scholar
  150. Noreika L, Pastor G, Liebman J (1981) Delayed emergence of antidepressant efficacy following withdrawal in olfactory bulbectomized rats. Pharmacol Biochem Behav 15:393–398Google Scholar
  151. Olds J (1958) Effects of hunger and male sex hormone on selfstimulation of the brain. J Comp Physiol Psychol 51:320–324Google Scholar
  152. O'Neill KA, Valentino D (1982) Escapability and generalization: Effect on behavioural despair. Eur J Pharmacol 78:379–380Google Scholar
  153. Parkes CM (1972) Bereavement: Studies of grief in adult life. International University Press, New YorkGoogle Scholar
  154. Paykel ES (1971) Classification of depressed patients: A cluster analysis derived grouping. Br J Psychiatry 118:275–288Google Scholar
  155. Paykel ES (1979) Recent life events in the development of the depressive disorders. In: Depue RA (ed) The psychobiology of the depressive disorders: Implications for the effects of stress. Academic Press, New York, pp 245–262Google Scholar
  156. Paykel ES, Coppen A (1979) Psychopharmacology of depression. Oxford University Press, OxfordGoogle Scholar
  157. Pearce JB (1981) Drug treatment of depression in children. Acta Paedopsychiatr 46:317–328Google Scholar
  158. Peterfy G, Pinter EJ, Pattee CJ (1976) Psychosomatic aspects of catecholamine depletion: Comparative aspects of metabolic, endocrine and affective changes. Psychoneuroendocrinology 1:243–253Google Scholar
  159. Petty F, Sherman AD (1980) Reversal of learned helplessness by imipramine. Commun Psychopharmacol 3:371–373Google Scholar
  160. Physicians Desk Reference, 36th edition (1982) Medical Economics Co., Oradell New JerseyGoogle Scholar
  161. Porsolt RD (1981) Behavioural despair. In: Enna SJ, Malick JB, Richelson E (eds) Antidepressants: Neurochemical, behavioural and clinical perspectives Raven Press, New York, pp 121–139Google Scholar
  162. Porsolt RD, Bertin A, Jalfre M (1977a) Behavioural, despair in mice: A primary screening test for antidepressants. Arch Int Pharmacodyn 229:327–336Google Scholar
  163. Porsolt RD, LePichon M, Jalfre M (1977b) Depression: A new animal model sensitive to antidepressant treatment. Nature 266:730–732Google Scholar
  164. Porsolt RD, Anton G, Blavet N, Jalfre M (1978a) Behavioural despair in rats, a new model sensitive to antidepressant treatments. Eur J Pharmacol 47:379–391Google Scholar
  165. Porsolt RD, Bertin A, Jalfre M (1978b) Behavioural despair in rats and mice: Strain differences and the effects of imipramine. Eur J Pharmacol 51:291–294Google Scholar
  166. Porsolt RD, Bertin A, Blavet M, Deniel M, Jalfre M (1979) Immobility induced by forced swimming in rats: Effects of agents which modify central catecholamine and serotonin activity. Eur J Pharmacol 57:201–210Google Scholar
  167. Poznanski EO (1982) The clinical phenomenology of childhood depression. Am J Orthopsychiatry 52:308–313Google Scholar
  168. Quinton RM (1963) The increase in the toxicity of yohimbine induced by imipramine and other drugs in mice. Br J Pharmacol 21:51–66Google Scholar
  169. Reite M, Short R, Seiler C, Pauley JD (1981) Attachment, loss and depression. J Child Psychol Psychiatry 22:141–169Google Scholar
  170. Robertson J, Bowlby J, (1952) Responses, of young children to separation from their mothers. Cour du Centre Internationale de L'Enfance 2:131–142Google Scholar
  171. Rosellini, RA (1978) Inescapable shock interferes with the acquisition of a free appetitive operant. Anim Learn Behav 6:155–159Google Scholar
  172. Rosellini RA, DeCola JP (1981) Inescabable shock interferes with the acquisition of a low-activity response in an appetitive context. Anim Learn Behav 9:487–490Google Scholar
  173. Roth KA, Katz RJ (1981) Further studies on a novel animal model of depression: therapeutic effects of a tricyclic antidepressant. Neurosci Biobehav Rev 5:253–258Google Scholar
  174. Sachar EJ, Hellman L, Roffwarg H, Halpern F, Fukushima D, Gallagher T (1973) Disrupted, 24-hour patterns of cortisol secretion in psychotic depression. Arch Gen Psychatry 28:19–24Google Scholar
  175. Sahakian BJ, Robbins TW, Morgan MJ, Iversen SD (1975) The effects of psychomotor stimulants on stereotypy and locomotor activity in socially deprived and control rats. Brain Res 84:195–205Google Scholar
  176. Sahakian BJ, Robbins TW, Iversen SD (1977) The effects of isolation rearing on exploration in the rat. Anim Learn Behav 5:193–198Google Scholar
  177. Sanghvi I, Gershon S (1969) The evaluation of central nervous system stimulants in a new laboratory test for antidepressants. Life Sci 8:449–457Google Scholar
  178. Sanghvi I, Bindler E, Gershon S (1969) The evaluation of a new animal method for the prediction of clinical antidepressant activity. Life Sci 8:99–106Google Scholar
  179. Sanghvi I, Geyer H Gershon S (1976) Exploration of the antidepressant potential of iprindole. Life Sci 18:569–574Google Scholar
  180. Schechter MD, Chance WT (1979) Non-specificity of “behavioural despair” as an animal model of depression. Eur J Pharmacol 60:139–142Google Scholar
  181. Scheckel CL, Boff E (1964) Behavioural effects of interacting imipramine and other drugs with d-amphetamine, cocaine and tetrabenazine. Psychopharmacology 5:198–208Google Scholar
  182. Schershlicht R, Polc P, Schneeberger J, Steiner M, Haefely W (1982) Selective supression of rapid eye movement sleep (REMS) in cats by typical and atypical antidepressants. In: Costa E, Racagni G (eds) Typical and atypical antidepressants: Molecular mechanisms Raven Press, New York, pp 359–364Google Scholar
  183. Schick JFE, Smith DE, Wesson DR (1973) An analysis of amphetamine toxicity and patterns of use. In: Smith DE, Wesson DR (eds) Uppers and downers. Prentice Hall, Englewood Cliffs, pp 23–61Google Scholar
  184. Schmale AH (1973) Adaptive role role of depression in health and disease. In: Scott JP Senay E (eds) Separation and depression. Am Assoc Adv Sci, Washington, pp 187–214Google Scholar
  185. Schulterband JG, Raskin A (1977) Depression in childhood: Diagnosis, treatment and conceptual models. Raven Press, New YorkGoogle Scholar
  186. Segal DS, Kuczenski R, Mandell AJ (1974) Theoretical implications of drug-induced adaptive regulation for a biogenic amine hypothesis of affective disorder. Biol Psychiatry 9:147–159Google Scholar
  187. Seligman MEP (1975) Helplessness: On depression, development and death. Freeman, San FranciscoGoogle Scholar
  188. Seligman MEP, Beagley G (1975) Learned helplessness in the rat. J Comp Physiol Psychol 88:534–541Google Scholar
  189. Seligman MEP, Rossellini RA, Kozak M (1975) Learned helplessness in the rat: Reversibility, time course and immunization. J Comp Physiol Psychol 88:542–547Google Scholar
  190. Sem-Jacobsen CW (1976) Electrical stimulation and self-stimulation in man with chronic implanted electrodes. Interpretation and pitfalls of results. In: Wauquier A, Rolls E (eds) Brain-stimulation reward. North Holland/American Elsevier, New York, pp 508–520Google Scholar
  191. Sherman AD, Sacquitne JL, Petty F (1982) Specificity of the learned helplessness model of depression. Pharmacol Biochem Behav 16:449–454Google Scholar
  192. Shopsin B, Cassano GB, Conti L (1981) An overview of new “second generation” antidepressant compounds: Research and treatment implications. In: Enna SJ, Malick JB, Richelson E (eds) Antidepressants: Neurochemical, behavioural and clinical perspectives. Raven Press, New York, pp 219–251Google Scholar
  193. Sigg EB, Hill RT (1967) The effect of imipramine on central adrenergic mechanisms. In: Brill H (ed) Neuro-psycho-pharmacology. Excerpta Medica. Amsterdam, pp 367–372Google Scholar
  194. Sigg EB, Gyermek L, Hill RT (1965) Antagonism to reserpine induced depression by imipramine, releated psychoactive drugs and some autonomic agents. Psychopharmacology 7:144–149Google Scholar
  195. Silvestrini B (1982) Trazodone—A new type of antidepressant: A discussion of pharmacological data and their clinical implications. In: Costa E, Racagni G (eds) Typical and atypical antidepressants: Molecular mechanisms. Raven Press New York pp 327–340Google Scholar
  196. Simpson DM, Annau Z (1977) Behavioural withdrawal following several psychoactive drugs. Pharmacol Biochem Behav 7:59–64Google Scholar
  197. Soblosky JS, Thurmond JB (1982) Tricyclic antidepressants and serotonin manipulations in an animal model of depression utilizing chronic intermittent stress. Soc Neurosci Abstr 8:464Google Scholar
  198. Sofia RD (1969a) Effects of centrally active drugs on experimentally-induced aggression in rodents. Life Sci 8:705–716Google Scholar
  199. Sofia RD (1969b) Structural relationship and potency of agents which selectively block mouse killing (muricide) behaviour in rats. Life Sci 8:1201–1210Google Scholar
  200. Spitz R (1946) Anaclitic depression. Psychoanal Stud Child 2:113–117Google Scholar
  201. Stein L (1962) New methods for evaluating stimulants and antidepressants. In: Nodine JH, Moyer JH (eds), The first Hahnemenn symposium on psychosomatic medicine. Lea and Fibiger, Philadelphia, pp 297–301Google Scholar
  202. Stein L, Seifter J (1961) Possible mode of antidepressive action of imipramine. Science 134:286–287Google Scholar
  203. Stille G, Lauener H, Eichenberger E, Matussek N, Poldinger W (1968) Observations concerning adrenergic functions and antidepressant activity. Pharmakopychiatr Neuropsychopharmakol 1:123–135Google Scholar
  204. Sulser F, Bickel MH, Brodie BB (1964) The action of desmethylimipramine in counteracting sedation and cholinergic effects of reserpine-like drugs. J Pharmacol Exp Ther 144:321–330Google Scholar
  205. Sulser F, Owens ML, Dingell JV (1966) On the mechanism of amphetamine potentiation by desipramine. Life Sci 5:2005–2010Google Scholar
  206. Sulser F, Vetulani J, Mobley PL (1978) Mode of action of antidepressant drugs. Biochem Pharmacol 27:257–261Google Scholar
  207. Suomi SJ (1976) Factors affecting responses to social separation in rhesus monkeys. In: Serban G, Kling A (eds) Animal models in human psychobiology. Plenum Press, New York, pp 9–26Google Scholar
  208. Suomi SJ, Harlow HF, Domek CJ (1970) Effect of repetitive infantinfant separation of young monkeys. J Abnorm Psychol 76:161–172Google Scholar
  209. Suomi SJ, Collins ML, Harlow HF (1976) Effect of maternal and peer separations on young monkeys J Child Psychol Psychiatr 17:101–112Google Scholar
  210. Suomi SJ, Seaman SF, Lewis JK, DeLizio RB, McKinney WT (1978) Effects of impramine treatment on separation-induced social disorders in rhesus monkeys. Arch Gen Psychiatry 34:321–325Google Scholar
  211. Szewczak MR, Fielding S, Cornfeldt M (1982) Rat internal capsule lesion: further characterization of antidepressant screening potential. Soc Neurosci Abstr 8:465Google Scholar
  212. Tennant C, Bebbington P, Hurry J (1981) The role of life events in depressive illness: is there a substantial causal connection? Psychol Med 11:379–389Google Scholar
  213. Theobald W, Buch O, Kunz H, Morpurgo C, Stenger EG, Wilhelmi G (1964) Comparative pharmacological studies with Tofranil, Pertofran and Ensidon. Arch Int Pharmacodyn Ther 148:560–569Google Scholar
  214. Turner C, Davenport R, Rogers C (1969) The effect of early deprivation on the social behaviour of adolescent chimpanzees. Am J Psychiatry 125:1531–1536Google Scholar
  215. Tyrer P (1979) Clinical use of monoamine oxidase inhibitors. In: Paykel ES, Coppen A (eds) Psychopharmacology of affective disorders. Oxford University Press, Oxford, pp 159–178Google Scholar
  216. Ueki S (1982) Mouse-killing behaviour (muricide) in the rat and the effect of antidepressants. In: Langer SZ, Takahashi R, Segawa T, Briley M (eds) New vistas in depression Pergamon Press, New York, pp 187–194Google Scholar
  217. Valenstein ES (1973) Brain control: A critical examination of brain stimulation and psychosurgery. Wiley, New YorkGoogle Scholar
  218. Valzelli L, Bernasconi S (1971) Psychoactive drug effects on behavioural changes induced by prolonged socio-environmental deprivation in rats. Psychol Med 6:271–276Google Scholar
  219. Valzelli L, Consolo S, Morpurgo C (1967) Influence of imipraminelike drugs on the metabolism of amphetamine. In: Garattini S, Dukes MNG (eds) Antidepressant drugs. Excerpta Medica, Amsterdam, pp 61–69Google Scholar
  220. Van Riezen H (1972) Different central effects of the 5-HT antagonists mianserin and cyproheptadine. Arch Int Pharmacodyn Ther 198:256–269Google Scholar
  221. Van Riezen H, Behagel H, Chafik M (1975) Development of psychotropic drugs. Psychopharmacol Bull 11:10–15Google Scholar
  222. Van Riezen H Schnieden H, Wren AF (1977) Olfactory bulb ablation in the rat: Behavioural changes and their reversal by antidepressant drugs. Br J Pharmacol 60:521–528Google Scholar
  223. Vogel JR, Hambrich DR (1973) Chronic administration of electroconvulsive shock: Effects on mouse killing activity and brain monoamines in rats. Physiol. Behav 11:725–728Google Scholar
  224. Wagner HR, Hall TL, Cote IL (1977) The applicability of inescapable shock as a source of animal depression. J Gen Psychol 96:313–318Google Scholar
  225. Wallach MD, Hedley LR (1979) The effects of antihistamines in a modified behavioural despair test. Commun Psychopharmacol 3:35–39Google Scholar
  226. Watanabe S, Inoue M, Ueki S (1979) Effects of psychotropic drugs injected into the limbic structures on mouse-killing behaviour in the rat with olfactory bulb ablation. Jpn J Pharmacol 29:493–496Google Scholar
  227. Watson R, Hartman E, Schildkraut JJ (1972) Amphetamine withdrawal: Affective state, sleep patterns and MHPG excretion. Am J Psychiatry 129:263–269Google Scholar
  228. Wauquier A (1980) The influence of psychoactive drugs on brain self-stimulation in rats: A review. In: Wauquier A, Rolls ET (eds) Brain stimulation reward. North Holland Amsterdam, pp 123–171Google Scholar
  229. Wehr TA, Wirz-Justice A (1982) Circadian rhythm mechanisms in affective illness and in antidepressant drug action. Pharmacopsychiatry 15:31–39Google Scholar
  230. Weingartner H, Silberman E (1982) Models of cognitive impairment: Cognitive changes in depression. Psychopharmacol Bull 18:27–42Google Scholar
  231. Weinstock M, Speiser A, Ashkenazi R (1976) Biochemical and pharmacological studies on an animal model of hyperactivity states. In: Gershon ES, Belmaker RH, Kety SS, Rosenbaum M (eds) The impact of biology on modern psychiatry Plenum. New York, pp 149–161Google Scholar
  232. Weinstock M, Speiser Z, Ashkenazi R (1978) Changes in brain catecholamine turnover and receptor sensitivity induced by social deprivation in rats. Psychopharmacology 56:205–209Google Scholar
  233. Weiss JM (1968) Effects of coping responses on stress. J Comp Physiol Psychol 65:251–260Google Scholar
  234. Weiss JM, Goodman PA, Losito BG, Corrigan S, Charry JM, Bailey WH (1981) Behavioural depression produced by an uncontrollable stressor: relationship to noreprinephrine, dopamine, and serotonin levels in various regions of rat brain. Brain Res Rev 3:167–205Google Scholar
  235. Willner P, Clark D (1978) A reappraisal of the interaction between tricyclic antidepressants and reserpine-like drugs. Psychopharmacology 58:55–62Google Scholar
  236. Zacharko RM, Bowers WJ, Kokkinidis L, Anisman H (1982) Alteration of intracranial self-stimulation in mice following inescapable stress. Soc Neurosci Abstr 8:898Google Scholar

Copyright information

© Springer-Verlag 1984

Authors and Affiliations

  • Paul Willner
    • 1
  1. 1.Department of PsychologyCity of London PolytechnicLondonUK

Personalised recommendations